HAA-09

• Target :

  Virus Protease|||Influenza Virus|||Others

• Related Pathways :

  Others|||Microbiology/Virology

• Bioactivity :

  HAA-09, an orally administered compound, serves as a powerful anti-influenza agent by targeting the influenza PB2_cap binding domain. It possesses significant activity against influenza A virus, exhibiting an EC50 of 0.03 ?M, and demonstrates polymerase inhibition with an IC50 of 0.06±0.004 ?M. Importantly, HAA-09 inhibits virus replication efficiently without inducing noticeable cytotoxicity [1].

• Smiles :

  FC=1C=C2C(=CNC2=NC1)C=3NC(=NN(CC(O)=O)C(C)(C)C)C(F)=CN3

• Molecular Formula :

  C17H18F2N6O2

• Molecular Weight :

  376.36

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1422051-33-9